Video

Optune User Journey: Meet Steve

Author(s):

Sponsored Content

Watch a video about Steve, an Optune user. Learn how Steve manages his treatment while enjoying his favorite activities.

Sponsored Content

Sponsored Content

Watch a video about Steve, an Optune user. Learn how Steve manages his treatment while enjoying his favorite activities at http://www.optune.com.

Hear firsthand from an Optune user and caregiver, like Steve.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of woman, with text.
Image of woman with text.
Image of man with text.
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
Image of Dr. Zhaoming Wang with text.
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Woman with text.
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Image of man with text.
Related Content
Image of woman.
July 25th 2025

Just a Little Off the Top: Taking the First Step in the Cancer Journey

Brenda Ohta
After brain surgery for a malignant tumor, I faced fears, found strength, and embraced living in the moment as I begin treatment and healing.
Site Logo
August 29th 2019

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
Image of brain.
July 17th 2025

FDA Grants Orphan Status to Liquid Glioma Treatment SH-110

Spencer Feldman
SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to swallow pills access therapy.
Site Logo
April 11th 2019

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
Image of brain tumor.
July 7th 2025

FDA Grants Orphan Drug Status to MB-101 for Glioblastoma, Astrocytomas

Spencer Feldman
The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.
Two patients treated with Temferon have lived three years post-surgery: © stock.adobe.com.
July 2nd 2025

Temferon Linked to Long-Term Survival in Some With Glioblastoma

Spencer Feldman
Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized after initial progression.